DEADLINE: MedChem Australia Round 3

Empowering Australian drug discovery
MedChem Australia is a national drug discovery initiative that works with the Australian biomedical research community and guides early-stage projects through the critical value creation steps where ‘hits’ are optimised to drug candidates with enhanced commercial value and clinical potential.

MedChem Australia provides expert medicinal chemistry & DMPK capability at 80% subsidised cost to selected projects to enhance, accelerate, and enable the development of new small molecule therapeutics. Projects to receive subsidised support are selected through a competitive and independent application process. Applications are invited through annual calls, with researchers from Australian Universities, Medical Research Institutes, and SMEs eligible to apply.